These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34021656)

  • 1. Minimally invasive surfactant therapy for moderate to late premature neonates with respiratory distress syndrome born in a non-tertiary unit.
    Tinoco Mendoza G; Allgood C; Tan A
    J Paediatr Child Health; 2021 Oct; 57(10):1658-1661. PubMed ID: 34021656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Minimally Invasive Surfactant Therapy vs Sham Treatment on Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome: The OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Tauscher MK; Murthy V; Ali SKM; Yossuck P; Clark HW; Soll RF; Carlin JB; Davis PG;
    JAMA; 2021 Dec; 326(24):2478-2487. PubMed ID: 34902013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally invasive surfactant therapy
    Elbaz Y; Portnov I; Lurie-Marcu B; Shinwell ES
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):6802-6806. PubMed ID: 34024234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-Year Outcomes After Minimally Invasive Surfactant Therapy in Preterm Infants: Follow-Up of the OPTIMIST-A Randomized Clinical Trial.
    Dargaville PA; Kamlin COF; Orsini F; Wang X; De Paoli AG; Kanmaz Kutman HG; Cetinkaya M; Kornhauser-Cerar L; Derrick M; Özkan H; Hulzebos CV; Schmölzer GM; Aiyappan A; Lemyre B; Kuo S; Rajadurai VS; O'Shea J; Biniwale M; Ramanathan R; Kushnir A; Bader D; Thomas MR; Chakraborty M; Buksh MJ; Bhatia R; Sullivan CL; Shinwell ES; Dyson A; Barker DP; Kugelman A; Donovan TJ; Goss KCW; Tauscher MK; Murthy V; Ali SKM; Clark HW; Soll RF; Johnson S; Cheong JLY; Carlin JB; Davis PG;
    JAMA; 2023 Sep; 330(11):1054-1063. PubMed ID: 37695601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimally invasive surfactant therapy versus InSurE in preterm neonates of 28 to 34 weeks with respiratory distress syndrome on non-invasive positive pressure ventilation-a randomized controlled trial.
    Gupta BK; Saha AK; Mukherjee S; Saha B
    Eur J Pediatr; 2020 Aug; 179(8):1287-1293. PubMed ID: 32462483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minimally invasive surfactant therapy failure: risk factors and outcome.
    Janssen LC; Van Der Spil J; van Kaam AH; Dieleman JP; Andriessen P; Onland W; Niemarkt HJ
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F636-F642. PubMed ID: 31036700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Catheter Choice on Procedural Success of Minimally Invasive Surfactant Therapy.
    Bhattacharya S; Read B; Miller M; da Silva O
    Am J Perinatol; 2023 Aug; 40(11):1202-1207. PubMed ID: 34560811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies.
    Aguar M; Cernada M; Brugada M; Gimeno A; Gutierrez A; Vento M
    Acta Paediatr; 2014 Jun; 103(6):e229-33. PubMed ID: 24628379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The minimal invasive surfactant therapy: experience from a low resource setting.
    Ajanwaenyi J; Bamidele O; Osim C; Salami O; Umukoro C; Idaboh T; Chimah U; Okolo A
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5177-5183. PubMed ID: 33491516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal continuous positive airway pressure versus nasal intermittent positive-pressure ventilation within the minimally invasive surfactant therapy approach in preterm infants: a randomised controlled trial.
    Oncel MY; Arayici S; Uras N; Alyamac-Dizdar E; Sari FN; Karahan S; Canpolat FE; Oguz SS; Dilmen U
    Arch Dis Child Fetal Neonatal Ed; 2016 Jul; 101(4):F323-8. PubMed ID: 26553376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimally invasive surfactant therapy versus intubation for surfactant administration in very low birth weight infants with respiratory distress syndrome.
    Wang XA; Chen LJ; Chen SM; Su PH; Chen JY
    Pediatr Neonatol; 2020 Apr; 61(2):210-215. PubMed ID: 31818537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pain and Physiological Stress During Minimally Invasive Surfactant Therapy (MIST) in Very Preterm Infants.
    Sawant T; Manerkar S; Patra S; Kalamdani P; Kalathingal T; Mondkar J
    Indian Pediatr; 2023 Jul; 60(7):557-560. PubMed ID: 37032545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lung recruitment improves the efficacy of intubation-surfactant-extubation treatment for respiratory distress syndrome in preterm neonates, a randomized controlled trial.
    Yang Y; Yan W; Ruan M; Zhang L; Su J; Deng H; Li M
    BMC Pediatr; 2022 Jan; 22(1):14. PubMed ID: 34980047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The OPTIMIST-A trial: evaluation of minimally-invasive surfactant therapy in preterm infants 25-28 weeks gestation.
    Dargaville PA; Kamlin CO; De Paoli AG; Carlin JB; Orsini F; Soll RF; Davis PG
    BMC Pediatr; 2014 Aug; 14():213. PubMed ID: 25164872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Minimally-invasive surfactant therapy in preterm infants on continuous positive airway pressure.
    Dargaville PA; Aiyappan A; De Paoli AG; Kuschel CA; Kamlin CO; Carlin JB; Davis PG
    Arch Dis Child Fetal Neonatal Ed; 2013 Mar; 98(2):F122-6. PubMed ID: 22684154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Surfactant replacement therapy with a minimally invasive technique: Experience in a tertiary hospital].
    Canals Candela FJ; Vizcaíno Díaz C; Ferrández Berenguer MJ; Serrano Robles MI; Vázquez Gomis C; Quiles Durá JL
    An Pediatr (Barc); 2016 Feb; 84(2):79-84. PubMed ID: 26028565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of less invasive surfactant administration versus intubation-surfactant-extubation on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome: a single-center, retrospective study from China.
    Xu CC; Bao YY; Zhao JX; Cheng K; Sun L; Wu JY; Wu MY; Zhu JJ
    BMC Pulm Med; 2022 Dec; 22(1):462. PubMed ID: 36471386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of minimally invasive pulmonary surfactant administration in preterm infants with neonatal respiratory distress syndrome: a multicenter clinical trial].
    Liu HQ; Tong XM; Han TY; Zhang H; Guo M; Zhang XF; Liu XJ; Zhang X; Zhang MT; Liu F; Bao LS; Zheng J; Tian XY; Gao Q; Zhang WX; Duan Y; Sun FF; Guo W; Li L; Xiao M; Liu WL; Jiang R
    Zhonghua Er Ke Za Zhi; 2020 May; 58(5):374-380. PubMed ID: 32392952
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.